MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness
Clinical trial NCT02427568 · COMPLETED
Trial details
- NCT number
- NCT02427568
- Sponsor
- Resilient Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-14
- Primary completion
- 2017-04-25
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.